Effects of a locally administered risedronate/autogenous bone graft combination on bone healing in a critical-size rabbit defect model

BACKGROUND: Risedronate is a bisphosphonate with poor oral absorption. An extremely hydrophilic molecule that has a high affinity for bone, risedronate also inhibits the farnesyl diphosphate synthase enzyme, inhibiting osteoclastic activity and reducing bone turnover and resorption. Autogenous bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Özer, Taha, Guliyeva, Vusala, Aktaş, Alper, Barış, Emre, Ocak, Mert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898954/
https://www.ncbi.nlm.nih.gov/pubmed/36737772
http://dx.doi.org/10.1186/s13018-023-03568-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898954/
https://www.ncbi.nlm.nih.gov/pubmed/36737772
http://dx.doi.org/10.1186/s13018-023-03568-0

Ejemplares similares